Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

LivaNova plc (LIVN) Ord GBP1 (DI)

Sell:$51.50 Buy:$51.51 Change: $0.015 (0.03%)
Market closed |  Prices as at close on 10 July 2020 | Switch to live prices |
Change: $0.015 (0.03%)
Market closed |  Prices as at close on 10 July 2020 | Switch to live prices |
Change: $0.015 (0.03%)
Market closed |  Prices as at close on 10 July 2020 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company's segments include Cardiac Surgery and Neuromodulation. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products. Cardiac Surgery products include oxygenators, heart-lung machines, autotransfusion, mechanical heart valves and tissue heart valves. The Neuromodulation segment is engaged in the design, development and marketing of neuromodulation therapy for the treatment of drug-resistant epilepsy and treatment resistant depression.

Contact details

20 Eastbourne Terrace
W2 6LG
United Kingdom
+44 (20) 33250662

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$2.50 billion
Shares in issue:
48.58 million
Health Care Equipment
Great Britain
US dollar
NASDAQ Comb. Composite

Key personnel

  • Daniel Moore
    Independent Chairman of the Board
  • Damien McDonald
    Chief Executive Officer, Director
  • Thad Huston
    Chief Financial Officer
  • Trui Hebbelinck
    Chief Human Resource Officer
  • Keyna Skeffington
    Senior Vice President, General Counsel and Company Secretary
  • Roy Khoury
    President - International, Senior Vice President - Global Strategic Marketing
  • Edward Andrle
    Special Advisor
  • Marco Dolci
    Head of Global Operations and R&D
  • Alistair Simpson
    Special Advisor

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.